COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ:OSIR) today announced that three abstracts describing the science and initial clinical evaluation of Grafix, a cellular wound care dressing, in the limb salvage and recalcitrant wound setting were accepted for presentation at the 24th Annual Symposium on Advanced Wound Care and Wound Healing Society. The abstract, “Characterization of novel human mesenchymal stem cell-containing skin substitutes for the treatment of wounds” by lead author Dr. Dana Yoo, was awarded the top score of all entries to the meeting as determined by a blinded review panel that evaluated submissions for their importance and relevance to the field of wound care research. Dr. Yoo will give a podium presentation on the subject in Session 41.1 on April 16.
